CRESCENT BIOPHARMA, INC. - CBIO
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | — | P | A | 525,897.0 | 14.499 | 7,624,980.6 | 2,294,037.0 | View | |
| Jul 20, 2026 | — | P | A | 853,450.0 | 14.5 | 12,375,025.0 | 3,601,316.0 | View | |
| Jun 23, 2026 | See Remarks | S | D | 465.0 | 17.99 | 8,365.35 | 13,871.0 | View | |
| Jun 23, 2026 | Chief Scientific Officer | S | D | 1,288.0 | 17.99 | 23,171.12 | 22,239.0 | View | |
| Jun 23, 2026 | Chief Financial Officer | S | D | 1,112.0 | 17.99 | 20,004.88 | 20,298.0 | View | |
| Jun 23, 2026 | See Remarks | S | D | 1,218.0 | 17.99 | 21,911.82 | 19,330.0 | View | |
| Jun 23, 2026 | Chief Medical Officer | S | D | 1,219.0 | 17.99 | 21,929.81 | 22,069.0 | View | |
| Jun 23, 2026 | President and COO | S | D | 20,549.0 | 17.99 | 369,676.51 | 139,158.0 | View | |
| Jun 23, 2026 | Chief Executive Officer | S | D | 42,305.0 | 17.99 | 761,066.95 | 281,212.0 | View | |
| Jun 03, 2026 | — | A | A | 11,050.0 | 0.0 | 0.0 | 11,050.0 | View | |
| Jun 03, 2026 | — | A | A | 11,050.0 | 0.0 | 0.0 | 11,050.0 | View | |
| Jun 03, 2026 | — | A | A | 11,050.0 | 0.0 | 0.0 | 11,050.0 | View | |
| Jun 03, 2026 | — | A | A | 11,050.0 | 0.0 | 0.0 | 11,050.0 | View | |
| Jun 03, 2026 | — | A | A | 11,050.0 | 0.0 | 0.0 | 11,050.0 | View |